SOTEVTAMAB
UNII YQ3YJK67AF

Substance Identification & Data

This profile provides standardized clinical and technical data for Sotevtamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YQ3YJK67AF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2411526-47-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
YQ3YJK67AF
CAS Registry Number
2411526-47-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SOTEVTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C121778
National Cancer Institute reference terminology for clinical and research data.
INN ID
11666
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sotevtamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOTEVTAMAB

Common Names & Synonyms

AB 16B5 [WHO-DD]
IMMUNOGLOBULIN G2, ANTI-(HUMAN CLUSTERIN .BETA.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL AB-16B5 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AB-16B5 .KAPPA.-CHAIN, DIMER
SOTEVTAMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus